Kewaunee Scientific Corporation
Description
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subsidiaries, and a national stocking distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
About
CEO
Mr. Thomas D. Hull III
Employees
1,006
Instrument type
Common Stock
Sector
Consumer Cyclical
Industry
Furnishings, Fixtures & Appliances
MIC code
XNMS
Address
2700 West Front Street, Statesville, NC 28677-2927, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Dec 9, 2025 | — | — | — | — |
| Sep 10, 2025 | — | — | — | — |
| Jun 25, 2025 | — | — | — | — |
| Mar 5, 2025 | — | — | — | — |
Earnings estimate
| Number of analysts | — | — | — | — |
|---|---|---|---|---|
| Average estimate | — | — | — | — |
| Low estimate | — | — | — | — |
| High estimate | — | — | — | — |
| Last year EPS | — | — | — | — |
[stock_revenue_estimate]
Growth estimates
Current qtr
—
Next qtr.
—
Current year
—
Next year
—
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 |
| Total reported revenue | 203.76M | 219.49M | 168.87M | 147.47M | 147.54M |
| Cost of revenue | 151.70M | 183.91M | 144.65M | 123.48M | 124.11M |
| Gross profit | 52.05M | 35.59M | 24.22M | 23.99M | 23.43M |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 4.18M | 71,000 | — | 1.15M | 454,000 |
| Other operating expenses | 33.77M | 30.22M | 26.83M | 25.31M | 25.77M |
| Operating income | 14.10M | 5.29M | -2.61M | -1.32M | -2.35M |
| Non operating interest income | |||||
| Income | — | — | — | — | — |
| Expense | 1.80M | 1.73M | 632,000 | 389,000 | 493,000 |
| Other income expense | 814,000 | 939,000 | 755,000 | -912,000 | -28,000 |
| Pretax income | 13.12M | 4.50M | -2.49M | -2.62M | -2.87M |
| Tax provision | -5.94M | 3.14M | 3.52M | 990,000 | 1.76M |
| Net income | 19.06M | 1.36M | -6.00M | -3.61M | -4.62M |
| Basic EPS | 6.51 | 0.26 | -2.20 | -1.33 | -1.70 |
| Diluted EPS | 6.38 | 0.25 | -2.20 | -1.33 | -1.70 |
| Basic average shares | 2.88M | 2.82M | 2.79M | 2.76M | 2.75M |
| Diluted average shares | 2.88M | 2.82M | 2.79M | 2.76M | 2.75M |
| EBITDA | 18.04M | 9.10M | 916,000 | 459,000 | 281,000 |
| Net income from continuing op. | 19.06M | 1.36M | -6.00M | -3.61M | -4.62M |
| Minority interests | -304,000 | -621,000 | -123,000 | -65,000 | -63,000 |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 |
| Total assets | 134.77M | 118.90M | 118.77M | 89.69M | 83.93M |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 23.27M | 8.08M | 4.43M | 5.21M | 4.37M |
| Other short term investments | — | — | — | — | — |
| Accounts receivable | 45.06M | 46.08M | 41.25M | 32.88M | 28.06M |
| Other receivables | — | — | — | — | — |
| Inventory | 20.68M | 21.89M | 23.80M | 16.52M | 15.33M |
| Prepaid assets | — | — | 6.16M | 4.37M | 2.91M |
| Restricted cash | 2.67M | 5.74M | 2.46M | 525,000 | 850,000 |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 5.14M | 6.14M | 6.16M | 4.37M | 2.91M |
| Non current assets | |||||
| Properties | 7.45M | 9.17M | 7.57M | 9.28M | 9.31M |
| Land and improvements | 41,000 | 41,000 | 41,000 | 41,000 | 41,000 |
| Machinery furniture equipment | 46.91M | 44.18M | 43.12M | 41.75M | 40.90M |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -46.59M | -44.97M | -45.21M | -42.82M | -41.59M |
| Goodwill | — | — | — | — | — |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 12.85M | 5.41M | 4.51M | 3.97M | 4.11M |
| Total liabilities | 78.56M | 80.41M | 82.59M | 47.90M | 45.23M |
| Current liabilities | |||||
| Accounts payable | 23.26M | 23.60M | 27.32M | 16.78M | 13.11M |
| Accrued expenses | 1.06M | 1.77M | 3.34M | 1.36M | 1.26M |
| Short term debt | 5.33M | 5.64M | 3.03M | 8.20M | 6.02M |
| Deferred revenue | 4.37M | 4.10M | 3.53M | 3.12M | 2.51M |
| Tax payable | — | — | — | — | — |
| Pensions | 6.04M | 4.30M | 4.50M | 4.73M | 4.16M |
| Other current liabilities | 713,000 | 642,000 | 575,000 | — | — |
| Non current liabilities | |||||
| Long term debt | 5.67M | 7.28M | 6.41M | 7.95M | 7.89M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 1.22M | 943,000 | 428,000 | 307,000 | 401,000 |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 27.88M | 28.59M | 29.31M | 806,000 | 569,000 |
| Shareholders equity | |||||
| Common stock | 7.27M | 7.08M | 6.98M | 6.92M | 6.89M |
| Retained earnings | 47.51M | 28.76M | 28.02M | 34.15M | 37.82M |
| Other shareholders equity | -3.38M | -3.44M | -3.74M | -3.58M | -9.60M |
| Total shareholders equity | 56.21M | 38.49M | 36.18M | 41.49M | 38.70M |
| Additional paid in capital | 5.41M | 5.06M | 4.48M | 3.81M | 3.36M |
| Treasury stock | 2.05M | 53,000 | 53,000 | 53,000 | 53,000 |
| Minority interest | 1.45M | 1.08M | 486,000 | 246,000 | 288,000 |
Cash flow statement
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1987 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||
| Net Income | 19.06M | 1.36M | -6.00M | -3.61M | -4.62M | 1.69M | 5.46M | 4.62M | 3.88M | 3.64M | 4.00M | 3.68M | 1.80M | 2.10M | 3.75M | 4.51M | 3.13M | 1.54M | 193,000 | -147,000 | 1.46M | -342,000 | 1.90M | 1.28M | 3.56M | 3.40M | 2.60M | 2.30M | 400,000 | -1.10M | -200,000 | -2.50M | 800,000 | 100,000 | 500,000 | 1.70M | — |
| Depreciation | 3.13M | 2.87M | 2.77M | 2.69M | 2.65M | 2.57M | 2.76M | 2.70M | 2.59M | 2.62M | 2.55M | 2.65M | 2.66M | 2.49M | 2.35M | 2.26M | 1.98M | 1.95M | 2.03M | 2.05M | 2.05M | 2.31M | 2.17M | 2.17M | 1.97M | 1.60M | 1.30M | 1.50M | 1.60M | 1.80M | 1.80M | 1.60M | 1.30M | 1.50M | 1.70M | 1.70M | — |
| Deferred Taxes | -7.13M | 516,000 | 120,000 | 1.66M | 1.90M | 202,000 | 1.13M | 234,000 | -335,000 | -513,000 | 864,000 | -526,000 | -1.54M | 223,000 | -393,000 | 547,000 | 940,000 | 541,000 | -66,000 | -561,000 | -565,000 | 717,000 | 196,000 | 355,000 | -255,000 | 500,000 | 300,000 | -600,000 | -100,000 | -400,000 | -300,000 | -500,000 | -100,000 | — | 200,000 | 500,000 | — |
| Stock-Based Compensation | 1.03M | 886,000 | 729,000 | 634,000 | 251,000 | 197,000 | 355,000 | 199,000 | 192,000 | 196,000 | 238,000 | 239,000 | 261,000 | 225,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 163,000 | 139,000 | 724,000 | 136,000 | 288,000 | 1.07M | 508,000 | -3,000 | 338,000 | -130,000 | -130,000 | -100,000 | 100,000 | -100,000 | 100,000 | 100,000 | -100,000 | 200,000 | 100,000 | — | -100,000 | -200,000 | — |
| Accounts Receivable | 741,000 | -4.95M | -7.51M | -3.11M | 2.12M | -664,000 | -3.12M | -2.09M | 1.20M | -5.69M | 2.30M | -2.67M | 4.66M | -1.24M | -1.81M | -4.58M | -1.22M | 4.00M | -1.80M | 2.78M | -9.30M | 2.58M | -1.51M | 220,000 | -885,000 | -3.40M | -1.30M | 100,000 | 2.30M | -600,000 | -300,000 | 3.80M | -4.00M | -1.60M | 1.40M | -200,000 | — |
| Accounts Payable | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | 1.77M | 967,000 | -9.97M | -1.97M | 3.52M | -1.51M | -8.35M | 5.28M | -1.68M | -1.02M | 866,000 | -2.18M | -681,000 | -1.39M | -515,000 | -993,000 | -1.89M | 1.23M | -3.27M | 852,000 | 1.97M | -2.27M | 518,000 | -356,000 | -621,000 | -100,000 | -1.00M | -1.30M | 100,000 | 500,000 | 600,000 | -600,000 | 1.00M | 900,000 | -300,000 | 700,000 | — |
| Operating Cash Flow | 18.60M | 1.65M | -19.86M | -3.71M | 5.81M | 2.48M | -1.77M | 10.94M | 5.85M | -772,000 | 10.82M | 1.19M | 7.17M | 2.41M | 3.55M | 1.89M | 3.68M | 9.41M | -2.63M | 6.05M | -3.88M | 2.99M | 3.62M | 3.53M | 3.64M | 1.90M | 2.00M | 1.90M | 4.40M | 300,000 | 1.50M | 2.00M | -900,000 | 900,000 | 3.40M | 4.20M | — |
| Investing Activities | |||||||||||||||||||||||||||||||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -2.55M | -1.72M | 614,000 | -976,000 | -1.62M | -2.64M | -2.07M | -1.68M | -3.35M | -3.70M | -1.50M | -1.20M | -500,000 | -800,000 | -800,000 | -1.30M | -900,000 | -800,000 | -500,000 | -800,000 | — |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -300,000 | — | — | — | — | — | — |
| Sale of Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 400,000 | 500,000 | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | 193,000 | 132,000 | 709,000 | -1.91M | 323,000 | 13,000 | -151,000 | -9,000 | -88,000 | 24,000 | -2.65M | -1.70M | 594,000 | -993,000 | -1.81M | -2.81M | -2.07M | -1.68M | -3.35M | -3.70M | -1.50M | -1.20M | -100,000 | -400,000 | -1.10M | -1.80M | -800,000 | -800,000 | -500,000 | -800,000 | — |
| Financing Activities | |||||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuance | 202,000 | 13.63M | 16.27M | — | — | — | — | — | — | — | 5.00M | — | — | 4.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | -148.64M | -58.72M | -64.60M | -60.12M | -64.80M | -58.20M | -59.69M | -52.06M | -50.27M | -421,000 | -3.85M | -236,000 | -283,000 | -215,000 | -220,000 | -362,000 | -360,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | -642,000 | -575,000 | — | -108,000 | -324,000 | -51,000 | -74,000 | -56,000 | -963,000 | -926,000 | -1.82M | -744,000 | — | — | -383,000 | -504,000 | — | — | — | — | — | — | — | — | — | — | — | — | -100,000 | — | — | 100,000 | — | — | — | 100,000 | — |
| Financing Cash Flow | -151.56M | -43.67M | -53.57M | -58.11M | -70.96M | -54.65M | -61.27M | -53.91M | -53.73M | -776,000 | -5.64M | -1.83M | -1.09M | 4.47M | -2.72M | -713,000 | 675,000 | -671,000 | -695,000 | -673,000 | -654,000 | -623,000 | -749,000 | -651,000 | -458,000 | -400,000 | -100,000 | -200,000 | -100,000 | — | — | -100,000 | -1.90M | -500,000 | -400,000 | — | — |
| Other Cash Details | |||||||||||||||||||||||||||||||||||||
| End Cash Position | 25.94M | 13.82M | 6.89M | 5.73M | 5.22M | 11.16M | 10.96M | 12.51M | 5.22M | 3.04M | 6.25M | 5.81M | 6.19M | 2.40M | 1.72M | 3.56M | 3.78M | 2.23M | 929,000 | 225,000 | 805,000 | 344,000 | 1.75M | 488,000 | 9,000 | — | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Paid | 6.24M | 3.16M | 1.01M | — | 188,000 | 2.46M | 2.87M | 2.62M | 2.39M | 1.87M | 2.59M | 1.72M | 418,000 | 1.47M | 1.31M | 994,000 | 1.11M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | 1.80M | 1.86M | 480,000 | 65,000 | 513,000 | 352,000 | 295,000 | 292,000 | 306,000 | 323,000 | 413,000 | 374,000 | 444,000 | 174,000 | 157,000 | 291,000 | 307,000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 15.19M | -7.94M | -9.79M | -1.49M | 1.70M | -1.72M | -212,000 | 9.05M | 5.08M | -277,000 | 6.05M | 1.42M | 5.49M | -3.98M | 294,000 | 600,000 | 845,000 | 6.98M | -2.13M | 2.17M | -2.56M | -3.68M | 2.39M | 688,000 | -1.16M | -2.40M | 1.90M | 3.00M | 2.60M | -1.10M | 1.10M | -300,000 | -3.40M | — | 3.30M | 4.00M | — |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 96,393 | 6.30M | 3.36% |
| DFA U.S. Small Cap Value Series | Oct 31, 2024 | 55,030 | 3.59M | 1.92% |
| Avantis U.S. Small Cap Value ETF | Nov 30, 2024 | 27,793 | 1.82M | 0.97% |
| DFA U.S. Micro Cap Series | Oct 31, 2024 | 26,379 | 1.72M | 0.92% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 24,128 | 1.58M | 0.84% |
| DFA U.S. Small Cap Series | Oct 31, 2024 | 16,600 | 1.08M | 0.58% |
| DFA U.S. Targeted Value Portfolio | Oct 31, 2024 | 16,167 | 1.06M | 0.56% |
| Dimensional ETF Tr-Dimensional U.S. Targeted Value ETF | Oct 31, 2024 | 14,204 | 927,805 | 0.49% |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | Sep 30, 2024 | 13,200 | 862,223 | 0.46% |
| Fidelity Extended Market Index Fund | Nov 30, 2024 | 11,736 | 766,595 | 0.41% |
Article
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Kewaunee Scientific manufactures laboratory furniture and equipment, a growing market driven by the need for advancements in healthcare. Since 2022, the company has focused on improving its margins through stop selling directly in some markets where the company had to focus on producing and selling. This has been reflected in the expansion of margins, but growth has been mid-single digit, and I think it can continue like this in the future.
Dec 16, 2024
Article
Kewaunee Scientific's Q2 Earnings Rise Y/Y Despite Sales Decline
KEQU reports fiscal Q2 earnings growth, driven by strong domestic demand and strategic acquisition of Nu Aire despite revenue challenges.
Dec 12, 2024
Article
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
STATESVILLE, N.C. , Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024.
Dec 11, 2024
